%0 Journal Article
%T 铁死亡在卵巢癌中的研究进展&#65306;从机制到治疗<br>Research Advances in Ferroptosis in Ovarian Cancer: From Mechanism to Therapy
%A 张柳青
%A 王云飞
%J Advances in Clinical Medicine
%P 2394-2404
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.153875
%X 卵巢癌是全球女性生殖系统中死亡率最高的一种恶性肿瘤&#65292;多数患者初次诊断即为晚期。现有的治疗方案是肿瘤细胞减灭术并辅以铂类为基础的联合化疗&#65292;但容易出现耐药和复发&#65292;因此迫切需要开发新的治疗方案。铁死亡是近年来发现的一种调节性细胞死亡形式&#65292;是铁依赖性的、非凋亡形式的细胞死亡过程。现有多项研究表明&#65292;铁死亡与卵巢癌相关。本文综述了铁死亡在卵巢癌中的发生机制、铁死亡诱导剂与抑制剂对卵巢癌的作用以及铁死亡在铂耐药卵巢癌中的应用&#65292;以期为后续的卵巢癌治疗提供新的思路和方向。<br>Ovarian cancer is a malignant tumor with the highest rate of mortality in the female reproductive system globally, however, and most patients are diagnosed at an advanced stage at first. The current treatment strategy of tumor cytoreduction supplemented with platinum-based combination chemotherapy is prone to drug resistance and relapse, necessitating the urgent need to develop new treatment options. Ferroptosis is a form of regulated cell death (RCD) discovered in recent years, and it is an iron-dependent, non-apoptotic form of cell death process. Several existing studies have shown that ferroptosis is associated with ovarian cancer. Therefore, this article reviews the mechanism of ferroptosis in ovarian cancer, the role of inducers and inhibitors of ferroptosis in ovarian cancer, and the application of ferroptosis in platinum-resistant ovarian cancer, with a view to providing new ideas and directions for subsequent ovarian cancer treatment.
%K 铁死亡&#65292
%K 卵巢癌&#65292
%K p53&#65292
%K 青蒿素&#65292
%K 铂耐药<br>Ferroptosis
%K Ovarian Cancer
%K p53
%K Artemisinin
%K Platinum Resistance
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=110139